Cargando…
Novel Cell Therapy Using Mesenchymal Stromal Cell Sheets for Medication-Related Osteonecrosis of the Jaw
Despite medication-related osteonecrosis of the jaw (MRONJ) being first reported in 2003, the optimal treatment and prevention modalities for MRONJ are not clear. As a result, dentistry, oral surgery, and departments involved in the treatment of cancer and bone diseases are struggling with the manag...
Autores principales: | Kaibuchi, Nobuyuki, Iwata, Takanori, Koga, Yoko Kawase, Okamoto, Toshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133503/ https://www.ncbi.nlm.nih.gov/pubmed/35646846 http://dx.doi.org/10.3389/fbioe.2022.902349 |
Ejemplares similares
-
Cytological character of mini pig mesenchymal stromal cells from various tissues and the attempt of cell sheet formation
por: Kaibuchi, Nobuyuki, et al.
Publicado: (2017) -
Wnt Signaling Inhibits High-Density Cell Sheet Culture Induced Mesenchymal Stromal Cell Aging by Targeting Cell Cycle Inhibitor p27
por: Xu, Ying, et al.
Publicado: (2020) -
The progress of medication-related osteonecrosis of the jaw with conservative initial treatment: A 12-year retrospective study of 129 patients
por: Kaibuchi, Nobuyuki, et al.
Publicado: (2021) -
Tips and Tricks and Clinical Outcome of Cryopreserved Human Amniotic Membrane Application for the Management of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Pilot Study
por: Odet, Stéphane, et al.
Publicado: (2022) -
Erratum: Tips and tricks and clinical outcome of cryopreserved human amniotic membrane application for the management of medication- related osteonecrosis of the jaw (MRONJ): A pilot study
por: Frontiers Production Office,
Publicado: (2022)